What is the BOLD stock price prediction for next 2 weeks?

According to our price prediction algorithm,Boundless Bio, Inc. (BOLD) price will be around $2.75 in the next 2 weeks. This means it will increase by 9.920000000000009 from the last closing price. This prediction may vary from other time period filters for BOLD stock.

What can be the highest Possible price of BOLD stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BOLD can achieve the highest price of $3.16 which is 26.206546687402632 higher than last closing price. This prediction may vary from other time period filters for BOLD stock.

What can be the lowest Possible price of BOLD stock in next 2 weeks?

As per the forecast and algorithmic analysis, BOLD stock price can be as low as $2.34 which is -6.544301782082443 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for BOLD stock.

Will BOLD stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that BOLD stock will gain9.920000000000009 in the next 2 weeks. This prediction may vary from other time period filters for BOLD stock.

What is BOLD stock last closing price?

Last closing price of BOLD stock was $2.50.

What is BOLD stock price prediction?

BOLD stock price prediction means predicting the future closing prices of BOLD stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BOLD stock in a certain time period.

How we predict BOLD stock future prices?

If you are searching for BOLD stock forecast, analysis or price prediction, then you might be wondering what Boundless Bio, Inc. (BOLD) will do in the future. Our BOLD price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BOLD price prediction will likely answer most of your questions.

How frequent we update BOLD stock predictions?

We are updating the forecasts for the BOLD stock on daily basis.

Is using ML forecasting for BOLD stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BOLD stock same for all the time periods?

No, the prediction for BOLD stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Boundless Bio, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$2.5074.83%Since 2 Weeks

Predicted Price$2.759.92%For 2 Weeks

Upper Predicted Price$3.1626.21%For 2 Weeks

Lower Predicted Price$2.34-6.54%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BOLD will rise by +9.92% over the next 2 Weeks and hit $2.75 by Thursday, July 16, 2026. In that time frame, BOLD's share price is expected to range between $2.34 and $3.16.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jul 16, 2026	2.10	2.50	2.90
Jul 15, 2026	2.07	2.50	2.93
Jul 14, 2026	2.13	2.53	2.94
Jul 13, 2026	1.83	2.25	2.70
Jul 10, 2026	1.98	2.39	2.80
Jul 9, 2026	1.93	2.36	2.77
Jul 8, 2026	1.96	2.36	2.79
Jul 7, 2026	1.96	2.38	2.81
Jul 6, 2026	1.72	2.11	2.52
Jul 3, 2026	1.85	2.24	2.68

BOLD shares rose +0.81% in Thursday, July 2, 2026's trading session, rising from a previous close of $2.48 to move at $2.50. The stock demonstrated notable intraday movement (see BOLD's key stats for a full breakdown), fluctuating between $2.45 and $2.60, a +6.12% trading range. While recent weeks have seen some volatility, BOLD has managed to secure a +74.83% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 139.28K shares changing hands, 189.89K fewer than the previous session. This amounted to $348.20K in total market activity.

Will BOLD Continue Its Upward Trend?

According to analyst ratings and projections for BOLD, Boundless Bio, Inc. shares are anticipated to increase by +13.78%, potentially reaching $2.90 per share by July 16, 2026. Short-term technical indicators currently suggest a neutral sentiment for BOLD. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the BOLD stock forecast, now is a good time to buy BOLD stock because its current trading price is -0.06% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BOLD covering social and institutional perspectives.

BOLD Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BOLD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 75.42% to 77.68%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 69.26%, suggests strong medium-term momentum. However, the 100-day RSI, at 60.36%, points to growing bullish momentum over the long term. Insights into BOLD's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Boundless Bio Short-Term Forecasts

BOLD Forecast For Next 5 Days

Our algorithm anticipates Boundless Bio (BOLD) stock could hit $1.67 by Jul 10, 2026. This represents a -33.16% fall from today's price, following a -0.81% change over the past five days.

BOLD Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Boundless Bio, Inc. (BOLD) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.02, which would mean a -19.20% decrease from the current price of $2.50. Projections for this period range from a high of $3.06 to a low of $1.34.

BOLD Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Boundless Bio's price over the next three months point to a drop. BOLD stock is expected to peak at $2.94 on Jul 30, 2026 after potentially dipping to $0.04 on Jul 07, 2026. On average, BOLD is likely to trade around $1.28 in the coming 90 days.

Boundless Bio Stock Forecast 2025

Based on our predictive models, Boundless Bio (BOLD) is expected to trade between $0.00 and $3.14 throughout 2026. This would result in an average price of $1.34, potentially offering investors a -46.40% return from current levels.

Boundless Bio, Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Boundless Bio, Inc. (BOLD) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.04 and $2.94, settling at an average of $1.43. This could translate to a -42.80% loss.

August 2026

Based on current market signals, Boundless Bio, Inc. is projected to trend august 2026. We forecast a trading range from $0.38 to $2.38, with a likely average price of $1.43. Investors could expect a potential return of -42.80%.

September 2026

Our predictive algorithms indicate Boundless Bio, Inc. stock may see a shift in September 2026. The expected range spans $0.25–$1.93, with an average target of $1.00. This represents a cautious outlook and a possible loss of -60.00%.

October 2026

Analyzing established trends, Boundless Bio, Inc. looks set to move in October 2026. Projections place the stock between $0.24 and $2.25, averaging around $1.22. This suggests a -51.20% loss from current levels.

November 2026

Market indicators suggest Boundless Bio, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $2.03, with a midpoint forecast of $0.92. The stock might deliver a -63.20% loss.

December 2026

Forecasting for December 2026, models estimate that Boundless Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.53 and $3.14, averaging $1.97. This signals a cautious trajectory with potential returns around -21.20%.

January 2027

According to our latest forecast models, Boundless Bio, Inc. (BOLD) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.64 and $2.63, settling at an average of $1.71. This could translate to a -31.60% loss.

February 2027

Based on current market signals, Boundless Bio, Inc. is projected to trend february 2027. We forecast a trading range from $0.00 to $1.51, with a likely average price of $0.40. Investors could expect a potential return of -84.00%.

March 2027

Our predictive algorithms indicate Boundless Bio, Inc. stock may see a shift in March 2027. The expected range spans $0.37–$2.15, with an average target of $1.28. This represents a cautious outlook and a possible loss of -48.80%.

April 2027

Analyzing established trends, Boundless Bio, Inc. looks set to move in April 2027. Projections place the stock between $0.70 and $2.64, averaging around $1.65. This suggests a -34.00% loss from current levels.

May 2027

Market indicators suggest Boundless Bio, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.88 to $3.20, with a midpoint forecast of $2.12. The stock might deliver a -15.20% loss.

June 2027

Forecasting for June 2027, models estimate that Boundless Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.23 and $2.31, averaging $1.25. This signals a cautious trajectory with potential returns around -50.00%.

July 2027

According to our latest forecast models, Boundless Bio, Inc. (BOLD) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.31 and $1.14, settling at an average of $0.67. This could translate to a -73.20% loss.

BOLD's history of dividends and stock splits also plays a role in long-term investor confidence.